Novo Nordisk A S 20-F for FY2022
Novo Nordisk A S (NVO)
20-F
2023-02-01
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 20-F
Novo Nordisk A S filed this 20-F on February 1, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 176.95B DKK
- up 25.7% from 140.8B DKK a year earlier
- Net income
- 55.53B DKK
- up 16.3% from net income of 47.76B DKK a year earlier
- Diluted EPS
- 24.44 DKK
- up 17.8% from 20.74 DKK a year earlier